These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 30666669

  • 1. Effect of atorvastatin on oxidative stress and inflammation markers in myxomatous mitral valve disease in dogs: A comparison of subclinical and clinical stages.
    Thassakorn P, Patchanee P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    J Vet Pharmacol Ther; 2019 May; 42(3):258-267. PubMed ID: 30666669
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inflammation and its association with oxidative stress in dogs with heart failure.
    Nemec Svete A, Verk B, Čebulj-Kadunc N, Salobir J, Rezar V, Domanjko Petrič A.
    BMC Vet Res; 2021 Apr 26; 17(1):176. PubMed ID: 33902566
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
    Surachetpong S, Jiranantasak T, Rungsipipat A, Orton EC.
    J Vet Cardiol; 2013 Sep 26; 15(3):171-80. PubMed ID: 23816827
    [Abstract] [Full Text] [Related]

  • 5. Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study.
    Apple SM, Menciotti G, Braz-Ruivo L, Crosara S, Häggström J, Borgarelli M.
    Aust Vet J; 2016 Sep 26; 94(9):324-8. PubMed ID: 27569835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
    Khaki Z, Nooshirvani P, Shirani D, Masoudifard M.
    BMC Vet Res; 2022 Dec 23; 18(1):448. PubMed ID: 36564735
    [Abstract] [Full Text] [Related]

  • 8. Short-term effects of atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease.
    Cunningham SM, Rush JE, Freeman LM.
    J Vet Intern Med; 2013 Dec 23; 27(4):985-9. PubMed ID: 23758137
    [Abstract] [Full Text] [Related]

  • 9. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun 23; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 10. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Jun 23; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 11. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C, Guglielmini C, Domenech O, Contiero B, Zini E, Poser H.
    PLoS One; 2020 Jun 23; 15(9):e0238440. PubMed ID: 32870923
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
    Reimann MJ, Häggström J, Møller JE, Lykkesfeldt J, Falk T, Olsen LH.
    J Vet Intern Med; 2017 Mar 23; 31(2):295-302. PubMed ID: 28132441
    [Abstract] [Full Text] [Related]

  • 18. How accurate are NT-proBNP, ANP, and cTnI levels in diagnosing dogs with myxomatous mitral valve disease?
    Chanmongkolpanit K, Riengvirodkij N, Channgam P, Kaenchan P, Buayam W, Janhirun Y, Phonarknguen R, Tansakul M, Sakcamduang W.
    Open Vet J; 2024 Jun 23; 14(6):1426-1441. PubMed ID: 39055758
    [Abstract] [Full Text] [Related]

  • 19. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
    Hezzell MJ, Boswood A, Chang YM, Moonarmart W, Elliott J.
    Am J Vet Res; 2012 Nov 23; 73(11):1765-74. PubMed ID: 23106462
    [Abstract] [Full Text] [Related]

  • 20. Biologic variability of N-terminal pro-brain natriuretic peptide in healthy dogs and dogs with myxomatous mitral valve disease.
    Winter RL, Saunders AB, Gordon SG, Buch JS, Miller MW.
    J Vet Cardiol; 2017 Apr 23; 19(2):124-131. PubMed ID: 28111138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.